This inventor holds 1 USPTO granted patent. Top assignee: Celtrix Pharmaceuticals, Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Cedo Martin Bagi and Bone Formation Research.
Introduction
Cedo Martin Bagi is an inventor associated with Sunnyvale, California, and Celtrix Pharmaceuticals, Inc. His patent concerns the use of insulin-like growth factor (IGF) and insulin-like growth factor-binding proteins (IGFBPs) to promote bone formation.
Latest Patents
Bagi is credited with 1 patent: “IGF/IGFBP Complex for Promoting Bone Formation and for Regulating Bone.” The invention describes administering IGF and IGFBP to stimulate new bone formation in people experiencing bone loss associated with a range of conditions, including bone marrow and connective tissue disorders, pregnancy, lactation, diabetes, juvenile osteoporosis, Paget’s disease, osteoarthritis, and periodontal disease. It also describes optionally combining IGF-I and IGFBP-3 with agents that inhibit bone resorption.
Career Highlights
Bagi’s listed work connects him with Celtrix Pharmaceuticals, Inc. and research into growth-factor-based approaches to bone formation. The patent addresses potential applications across multiple causes of bone loss.
Collaborations
Bagi’s listed coworkers include Robert Brommage and David M. Rosen. Their names are associated with his professional context in the supplied information.
Conclusion
Cedo Martin Bagi’s patent reflects an effort to apply IGF and IGFBP research to stimulating bone formation and addressing bone loss across diverse conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile